[26-000176] the nhlbi cellular and molecular therapeutics branch requires a scientist in order to develop/oversee research projects aiming at identifying genetic risk factors in the development of…

Active Awarded Last action

Contract number
75N92026F00005
Awardee
Awarding agency
Obligated
$239,054

Award facts

Contract value 100% obligated
$239,053.60 Current and potential, with all options
Completion date 93% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
West McLean, VA 22102, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The National Heart, Lung, and Blood Institute (NHLBI) awarded a $239,053.60 firm fixed-price BPA call to Guidehouse Digital LLC to support the Cellular and Molecular Therapeutics Branch in developing and overseeing research projects focused on identifying genetic risk factors associated with myeloid malignancies in sickle cell disease patients. This contract, which extends through November 18, 2026, will be performed in West McLean, Virginia. The award was made through a competitive process with no set-aside designation, allowing Guidehouse Digital LLC to compete on a full and open basis for this scientific staffing and research support requirement.

This BPA call draws from Guidehouse Digital LLC's existing $49 million Blanket Purchase Agreement with NHLBI for professional and scientific support services. The contractor, a global management and technology consulting firm headquartered in McLean, Virginia, brings extensive experience in biomedical research support, scientific computing, clinical research administration, and specialized staffing to federal agencies. This engagement supports NHLBI's research mission within the National Institutes of Health to advance understanding of blood disorders and cardiovascular health, with this particular effort contributing to the agency's work in understanding genetic contributions to hematologic malignancies in vulnerable patient populations.

Description

[26-000176] the nhlbi cellular and molecular therapeutics branch requires a scientist in order to develop/oversee research projects aiming at identifying genetic risk factors in the development of myeloid malignancies in sickle cell disease patients

Quick answers

Who was awarded contract 75N92026F00005?

75N92026F00005 was awarded to Guidehouse Digital LLC by National Heart Lung and Blood Institute (National Institutes of Health) on November 19, 2025.

How much is contract 75N92026F00005 worth?

The government has obligated $239,054 on 75N92026F00005.

Is contract 75N92026F00005 an order under another contract?

Yes. 75N92026F00005 is a BPA call under GS10F039AA-75N92025A00008, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 75N92026F00005 competed?

The extent of competition for 75N92026F00005 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award